Gastroendoscopes - Market Insights, Competitive Landscape, and Market Forecast - 2030

The Gastroendoscopes market is expected to grow at a steady CAGR forecast till 2030 owing to the increase in incidence of gastrointestinal cancer and stomach cancer, growing adoption of minimally invasive surgeries across the globe, and growing technical advancement leading to increase in product development activities in the domain of gastroendoscopes.

The global gastroendoscopes market was valued at USD 3.08 billion in 2023, growing at a CAGR of 6.69% during the forecast period from 2024 to 2030 to reach USD 4.53 billion by 2030. The gastroendoscopes market is witnessing a positive market growth owing to the factors such as the increasing prevalence of various gastrointestinal diseases such as gastro-esophageal reflux disease (GORD), growing prevalence of stomach cancer and esophageal cancer, rising cases of gastrointestinal procedures. Additionally, the market growth is further accelerated by continuous innovation and the launch of advanced gastroendoscopes, alongside regulatory approvals. This expansion of treatment options enhances positive patient outcomes and propels market growth from 2024 to 2030.

Gastroendoscopes Market Dynamics:

As per the latest data provided by World Cancer Research Fund International, in 2022, globally, there were more than 968,784 new cases of stomach cancer. Stomach cancer is the 5th most common cancer worldwide. It is the 4th most common cancer in men and the 7th most common cancer in women.

Additionally, according the recent data provided by International Agency for Research on Cancer (2024), globally, the incidence for gastrointestinal cancer was 4.8 million.

Stomach and gastrointestinal cancers significantly boost the market for gastroendoscopes by driving the need for early detection, accurate diagnosis, and effective treatment options. As these cancers often present with subtle symptoms that require precise diagnostic tools, gastroendoscopes are increasingly relied upon for their ability to provide high-resolution, real-time imaging of the gastrointestinal tract. This enables early identification of cancerous lesions and facilitates biopsies that are critical for accurate diagnosis. The demand for gastroendoscopes is further heightened by the growing preference for minimally invasive procedures, which are essential for treating these cancers while minimizing patient trauma and thereby boosting the overall market across the globe.

Along with the factors mentioned above, technological advancements in the field of gastroendoscopy such as the development of new gastroendoscopic techniques such as dual types of gastroendoscopes that can be used for both upper and lower tract with the aim to enhance the yield and diagnostic accuracy are also expected to aid in the growth of the gastroendoscopes market. For instance, on October 20, 2021, FUJIFILM Healthcare Americas Corporation announced the launch of its El-740D/S dual-channel endoscope. Fujifilm's EI-740D/S is the first dual-channel endoscope cleared by the US FDA for use in both upper and lower gastrointestinal applications.

Thus, the factors mentioned above are likely to boost the market of gastroendoscopes during the forecasted period.

However, postoperative complications associated with gastroendoscopy such as internal bleeding, tearing (perforation) of the lining of the esophagus, stomach, or duodenum, and abnormal reaction to the sedative, including breathing or heart problems may be certain limiting factors of the gastroendoscopes market growth.

Gastroendoscopes Market Segment Analysis:

Gastroendoscopes Market by Product Type (Surgical Endoscopes, Capsule Endoscopes, Transnasal Gastroscopes, Dual Channel Gastroscopes, and Others), Device Type (Rigid Endoscopes and Flexible Endoscopes), Procedure (Upper Gastrointestinal and Lower Gastrointestinal), End-User (Hospitals, Diagnostic Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the overall gastroendoscopes market, the capsule endoscopes are expected to hold the largest share in the year 2023. Capsule endoscopes are significantly boosting the market for gastroendoscopes by expanding the capabilities and applications of endoscopic procedures. Capsule endoscopes offer a non-invasive, patient-friendly alternative for examining the entire gastrointestinal (GI) tract, particularly areas like the small intestine that are difficult to reach with conventional endoscopes. This innovation is especially valuable for diagnosing conditions such as Crohn's disease, celiac disease, obscure GI bleeding, and small bowel tumors, where traditional methods may fall short.
Another added advantage associated with capsule endoscopes is that they can be used to access both the upper and lower tract without being restricted to upper-tract applications. Additionally, the recent technological advancement in capsule endoscopy is also playing a major role in boosting the overall market for capsule endoscopy. For instance, in January 2024, AnX Robotica announced the FDA clearance of NaviCam ProScan, the first AI-assisted reading tool designed to aid small bowel capsule endoscopy.

Hence, all the above-mentioned factors are expected to generate considerable revenue of the segment pushing the overall growth of the global gastroendoscopes market during the forecast period.

North America is expected to dominate the overall gastroendoscopes market:

Among all the regions, North America is expected to hold the largest share in the global gastroendoscopes market in 2023. Owing to significant growth factors such as rising prevalence of gastrointestinal and esophageal cancer, rising government initiatives. Additionally, presence of sophisticated healthcare infrastructure and a viable market in terms of product launches and product approvals are expected to aid in the growth of the North American gastroendoscopes market during the forecast period from 2024 to 2030.

According to the latest data provided by the American Cancer Society, in 2024 there were about 22,370 new esophageal cancer cases diagnosed in the United States of which 17,690 cases of esophageal cancer were in men and 4,680 in women.

Additionally, American Gastrointestinal Association (2022), launched the "Trust Your Gut" awareness campaign, aiming to reduce delays between the onset of bowel symptoms and discussions with healthcare providers. The campaign highlighted new data revealing that nearly 40% of Americans had stopped routine activities due to uncomfortable bowel symptoms in the past year, including exercising (19%), running errands (17%), and spending time with family and friends (16%). Despite this impact, many remained reluctant to discuss their symptoms with medical professionals, with 1 in 3 indicating they would only do so if prompted by their doctor. Thus, the increased awareness and discomfort associated with bowel symptoms may drive more individuals to seek medical evaluations, including endoscopic procedures. This heightened awareness can lead to more referrals for gastroendoscopy as patients become more proactive about addressing gastrointestinal issues, ultimately boosting the market for gastroendoscopes. Further, the increasing number of product development activities in the region is further going to accelerate the growth of the gastroendoscopes market. For instance, in March 2023, NexOptic Technology Corp., an AI and imaging solutions firm, signed a non-binding MOU with IntroMedic Co., Ltd., a South Korean company known for its capsule endoscopy products. IntroMedic's MicroCam capsule endoscope offers a 12-hour operational duration and a 170-degree view of the digestive tract. This collaboration aimed to enhance image quality in capsule endoscopy procedures, thereby improving patient outcomes.

Therefore, the above-mentioned factors are expected to bolster the growth of the gastroendoscopes market in the North America during the forecast period.

Gastroendoscopes Market Key Players:

Some of the key market players operating in the gastroendoscopes market include Olympus Corporation, Boston Scientific Corporation, CONMED Corporation, Ambu A/S, PENTAX Medical, KARL STORZ SE & Co. KG, Shaili Endoscopy, Stryker, FUJIFILM Healthcare Americas Corporation, Medtronic PLC, Albyn Medical Ltd., Creo Medical, CapsoVision, Inc., Changzhou JIUHONG Medical Instrument Co., Ltd., Arthrex Inc., and others.

Recent Developmental Activities in the Gastroendoscopes Market:

• In February 2022, Ambu announced FDA clearance of single-use gastroscope and next-generation display unit.
• In August, 2021, The Ambu® aScope™ Duodeno received a CE mark and is ready to be used at healthcare centers in Europe. The product was already been commercialized in the USA since December 2020. The aScope™ Duodeno is Ambu’s first device for GI (gastrointestinal) endoscopy.

Key Takeaways From the Gastroendoscopes Market Report Study:

• Market size analysis for current gastroendoscopes size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the gastroendoscopes market.
• Various opportunities available for the other competitors in the gastroendoscopes market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current gastroendoscopes market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for gastroendoscopes market growth in the coming future?

Target Audience who can be Benefited From This Gastroendoscopes Market Report Study:

• Gastroendoscopes product providers
• Research organizations and consulting companies
• Gastroendoscopes -related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in gastroendoscopes
• Various end-users who want to know more about the gastroendoscopes market and the latest technological developments in the gastroendoscopes market.

Frequently Asked Questions for the Gastroendoscopes Market:

1. What are gastroendoscopes?

• A gastroendoscopes is a device that is used in the visualization of the internal anatomy of the oesophagus, stomach, and duodenum.

2. What is the market for gastroendoscopes?

• The global gastroendoscopes market was valued at USD 3.08 billion in 2023, growing at a CAGR of 6.69% during the forecast period from 2024 to 2030 to reach USD 4.53 billion by 2030.

3. What are the drivers for the gastroendoscopes market?

• The gastroendoscopes market is witnessing a positive market growth owing to the factors such as the increasing prevalence of various gastrointestinal diseases such as gastro-oesophageal reflux disease (GORD), growing prevalence of stomach cancer and oesophageal cancer, rising cases of gastrointestinal procedures. Market growth is further accelerated by continuous innovation and the launch of advanced gastroendoscopes, alongside regulatory approvals. This expansion of treatment options and increased competition enhances patient outcomes and propels market growth from 2024 to 2030.

4. Who are the key players operating in the gastroendoscopes market?

• Some of the key market players operating in the Gastroendoscopes market include Olympus Corporation, Boston Scientific Corporation, CONMED Corporation, Ambu A/S, PENTAX Medical, KARL STORZ SE & Co. KG, Shaili Endoscopy, Stryker, FUJIFILM Healthcare Americas Corporation, Medtronic PLC, Albyn Medical Ltd., Creo Medical, CapsoVision, Inc., Changzhou JIUHONG Medical Instrument Co., Ltd., and others.

5. Which region has the highest share in the gastroendoscopes market?

• Among all the regions, North America is expected to hold the largest share in the global gastroendoscopes market in 2023. Owing to significant growth factors such as rising prevalence of gastrointestinal and esophageal cancer, rising government initiatives. Additionally, presence of sophisticated healthcare infrastructure and a viable market in terms of product launches and product approvals are expected to aid in the growth of the North American gastroendoscopes market during the forecast period from 2024 to 2030.

This product will be delivered within 2 business days.